Teladoc Company Profile (NYSE:TDOC)

About Teladoc (NYSE:TDOC)

Teladoc logoTeladoc, Inc. is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company's solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. As of December 31, 2016, it served over 7,500 employers, health plans, health systems and other entities. As of December 31, 2016, these clients collectively purchased access to its solution for more than 17.5 million Members. As of December 31, 2016, it had over 30 health plans as Clients. Its solutions consist of an integrated technology platform, Provider network, consumer engagement strategies and entrenched distribution channels.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Information Services
  • Sub-Industry: N/A
  • Symbol: NYSE:TDOC
  • CUSIP: N/A
  • Web:
  • Market Cap: $1.66 billion
  • Outstanding Shares: 54,459,000
Average Prices:
  • 50 Day Moving Avg: $26.54
  • 200 Day Moving Avg: $21.41
  • 52 Week Range: $10.29 - $30.98
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -69.32
  • P/E Growth: -1.65
Sales & Book Value:
  • Annual Revenue: $139.17 million
  • Price / Sales: 11.94
  • Book Value: $6.32 per share
  • Price / Book: 4.83
  • EBIDTA: ($43,100,000.00)
  • Net Margins: -69.15%
  • Return on Equity: -32.68%
  • Return on Assets: -25.11%
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 4.50%
  • Quick Ratio: 4.50%
  • Average Volume: 799,552 shs.
  • Beta: 0.27
  • Short Ratio: 14.1

Frequently Asked Questions for Teladoc (NYSE:TDOC)

What is Teladoc's stock symbol?

Teladoc trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

How were Teladoc's earnings last quarter?

Teladoc Inc (NYSE:TDOC) issued its quarterly earnings data on Monday, May, 8th. The company reported ($0.30) earnings per share for the quarter, beating analysts' consensus estimates of ($0.33) by $0.03. The company had revenue of $42.90 million for the quarter, compared to the consensus estimate of $42.22 million. Teladoc had a negative return on equity of 32.68% and a negative net margin of 69.15%. The firm's revenue for the quarter was up 59.5% compared to the same quarter last year. During the same quarter last year, the company earned ($0.40) earnings per share. View Teladoc's Earnings History.

What guidance has Teladoc issued on next quarter's earnings?

Teladoc issued an update on its FY17 earnings guidance on Monday, May, 8th. The company provided earnings per share guidance of ($0.91)-($0.85) for the period, compared to the Thomson Reuters consensus EPS estimate of ($0.88). The company issued revenue guidance of $180-$185 million, compared to the consensus revenue estimate of $182.79 million.Teladoc also updated its Q2 guidance to ($0.28)-($0.26) EPS.

Where is Teladoc's stock going? Where will Teladoc's stock price be in 2017?

13 brokers have issued 12-month price objectives for Teladoc's stock. Their forecasts range from $20.00 to $37.00. On average, they expect Teladoc's share price to reach $29.08 in the next year. View Analyst Ratings for Teladoc.

What are analysts saying about Teladoc stock?

Here are some recent quotes from research analysts about Teladoc stock:

  • 1. According to Zacks Investment Research, "Teladoc fist quarter loss came in below the Zacks Consensus loss estimate.  It is witnessing steady business growth with insurers and customers increasingly embracing tele-health. With five acquisitions completed since its inception, the insurer has expanded its distribution capabilities and broadened its service offering.has incurred significant losses in each period since its inception. The company is plaintiff in two lawsuits in the Texas courts against the Texas Medical Board Business. Its inability to adapt its business model in compliance with the revised rules could substantially hamper its financial performance. However, Year to date the stock has given a stupendous performance outperforming the Zacks categorized Medical Services industry." (5/11/2017)
  • 2. Cowen and Company analysts commented, "We are positive on TDOC's partnership with Accolade as it should help drive utilization for members entitled to both benefits. For clients with the combined offering, it has demonstrated improvements in utilization, with mgmt noting ~30% higher utilization. The partnership is already embedded into 2017 guidance, which gives us incremental comfort in the implied utilization ramp." (3/16/2017)
  • 3. Chardan Capital analysts commented, "After market close on Wed., TDOC reported earnings with a beat and a mixed guide for 2017. For 4Q16, Teladoc beat the Street consensus by 2% on the topline and by $0.04 on the bottom line. Management guided to topline growth in 2017 of 48%, in-line with Street consensus and re-affirmed its target of being adj. EBITDA breakeven in 4Q17. Management also guided to more EBITDA loss in 2017 than the Street expected in the first 3 quarters driven by various investments in growth. We adjust our estimates down slightly and in-line with Management Guidance for 2017. We raise our PT to $28 based on multiple expansion we see in 2017 as TDOC's operating characteristics improve relative to valuation comps and investor confidence grows in the company's execution." (3/2/2017)
  • 4. Cantor Fitzgerald analysts commented, "We estimate net proceeds to the company will be about $105 million. In addition, 1.6 million shares were sold by certain shareholders. With the capital raise, TDOC has put to bed any concerns that may have existed about its ability to fund near term losses, which we expect to narrow during the course of 2017. Net cash now stands at about $135 million and we expect the company to use about $20-25 million in cash in 2017. With the higher share count, our estimated loss per share declines to $0.43 from $0.50. Assuming no other changes in our DCF, our price target declines from $25 to $23 after factoring the additional share count and cash proceeds. The shares offer 35% upside to our revised target price. Our rating remains at Overweight." (1/19/2017)

Who are some of Teladoc's key competitors?

When did Teladoc IPO?

(TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Who owns Teladoc stock?

Teladoc's stock is owned by many different of retail and institutional investors. Top institutional shareholders include FMR LLC (14.94%), Wellington Management Group LLP (7.80%), Vanguard Group Inc. (5.03%), Alliancebernstein L.P. (4.21%), JPMorgan Chase & Co. (2.96%) and Janus Capital Management LLC (2.74%). Company insiders that own Teladoc stock include Adam C Vandervoort, Dana G Jr Mead, James K Outland, Jason N Gorevic, Lp Chp III, Mark Hirschhorn, Michael H King, Trident Capital Fund Vi Lp and William H Frist. View Institutional Ownership Trends for Teladoc.

Who sold Teladoc stock? Who is selling Teladoc stock?

Teladoc's stock was sold by a variety of institutional investors in the last quarter, including Cortina Asset Management LLC, CWM LLC, Massachusetts Financial Services Co. MA, PNC Financial Services Group Inc., Prudential Financial Inc., Daiwa SB Investments Ltd., DF Dent & Co. Inc. and Emerald Advisers Inc. PA. Company insiders that have sold Teladoc stock in the last year include Adam C Vandervoort, James K Outland, Jason N Gorevic, Lp Chp III, Mark Hirschhorn, Michael H King and Trident Capital Fund Vi Lp. View Insider Buying and Selling for Teladoc.

Who bought Teladoc stock? Who is buying Teladoc stock?

Teladoc's stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, JPMorgan Chase & Co., Alliancebernstein L.P., Janus Capital Management LLC, Eagle Asset Management Inc., Wellington Management Group LLP, Vanguard Group Inc. and Loomis Sayles & Co. L P. Company insiders that have bought Teladoc stock in the last two years include Dana G Jr Mead and William H Frist. View Insider Buying and Selling for Teladoc.

How do I buy Teladoc stock?

Shares of Teladoc can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Teladoc stock cost?

One share of Teladoc stock can currently be purchased for approximately $30.50.

Analyst Ratings

Consensus Ratings for Teladoc (NYSE:TDOC) (?)
Ratings Breakdown: 3 Hold Ratings, 10 Buy Ratings
Consensus Rating:Buy (Score: 2.77)
Consensus Price Target: $29.08 (4.64% downside)

Analysts' Ratings History for Teladoc (NYSE:TDOC)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/24/2017Canaccord GenuityReiterated RatingBuy$34.00HighView Rating Details
5/17/2017KeyCorpInitiated CoverageOverweight -> Overweight$37.00HighView Rating Details
5/12/2017Craig HallumDowngradeBuy -> Hold$28.00 -> $32.00LowView Rating Details
5/9/2017Robert W. BairdReiterated RatingBuy$28.00LowView Rating Details
5/9/2017Chardan CapitalBoost Price TargetBuy -> Buy$28.00 -> $30.00HighView Rating Details
4/11/2017Piper Jaffray CompaniesBoost Price TargetOverweight$26.00 -> $32.00MediumView Rating Details
4/6/2017Cantor FitzgeraldDowngradeOverweight -> Neutral$23.00 -> $27.00LowView Rating Details
3/16/2017Cowen and CompanyReiterated RatingOutperform$29.00LowView Rating Details
3/2/2017Oppenheimer Holdings Inc.Set Price TargetBuy$23.00 -> $27.00N/AView Rating Details
8/28/2016FBR & CoReiterated RatingBuyN/AView Rating Details
8/4/2016Deutsche Bank AGLower Price TargetBuy$21.00 -> $20.00N/AView Rating Details
6/1/2016Stifel NicolausInitiated CoverageHoldN/AView Rating Details
5/31/2016Jefferies Group LLCReiterated RatingOutperform$25.00N/AView Rating Details
4/1/2016Leerink SwannReiterated RatingOutperformN/AView Rating Details
3/7/2016SunTrust Banks, Inc.Lower Price TargetBuy$37.00 -> $21.00N/AView Rating Details
3/3/2016Royal Bank of CanadaLower Price TargetOutperform$35.00 -> $20.00N/AView Rating Details
10/4/2015William BlairReiterated RatingBuyN/AView Rating Details
10/4/2015Wells Fargo & CoReiterated RatingBuyN/AView Rating Details
9/21/2015JPMorgan Chase & Co.Reiterated RatingBuyN/AView Rating Details
(Data available from 5/26/2015 forward)


Earnings History for Teladoc (NYSE:TDOC)
Earnings by Quarter for Teladoc (NYSE:TDOC)
Earnings History by Quarter for Teladoc (NYSE:TDOC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2017Q1 2017($0.33)($0.30)$42.22 million$42.90 millionViewListenView Earnings Details
3/1/2017Q416($0.35)($0.31)$36.73 million$37.40 millionViewListenView Earnings Details
10/27/2016Q316($0.36)($0.33)$32.29 million$32.40 millionViewListenView Earnings Details
8/3/2016Q216($0.39)($0.38)$28.20 million$26.50 millionViewN/AView Earnings Details
5/10/2016Q116($0.38)($0.40)$26.64 million$26.90 millionViewListenView Earnings Details
3/2/2016Q415($0.41)($0.39)$21.89 million$22.60 millionViewN/AView Earnings Details
11/2/2015Q315($0.35)($0.35)$19.31 million$19.97 millionViewN/AView Earnings Details
8/12/2015Q215($0.43)($0.46)$17.06 million$18.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Teladoc (NYSE:TDOC)
Current Year EPS Consensus Estimate: $-0.88 EPS
Next Year EPS Consensus Estimate: $-0.44 EPS


Dividend History for Teladoc (NYSE:TDOC)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Teladoc (NYSE:TDOC)
Insider Ownership Percentage: 5.94%
Institutional Ownership Percentage: 46.61%
Insider Trades by Quarter for Teladoc (NYSE:TDOC)
Institutional Ownership by Quarter for Teladoc (NYSE:TDOC)
Insider Trades by Quarter for Teladoc (NYSE:TDOC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/23/2017Jason N GorevicCEOSell14,400$29.57$425,808.00View SEC Filing  
5/17/2017Mark HirschhornVPSell100,000$27.70$2,770,000.00View SEC Filing  
5/8/2017Jason N GorevicCEOSell15,000$23.11$346,650.00View SEC Filing  
4/19/2017Mark HirschhornVPSell59,100$25.46$1,504,686.00View SEC Filing  
4/19/2017Michael H KingInsiderSell5,000$25.75$128,750.00View SEC Filing  
1/26/2017Mark HirschhornVPSell900$20.00$18,000.00View SEC Filing  
1/24/2017Jason N GorevicCEOSell100,000$15.79$1,579,000.00View SEC Filing  
1/24/2017Trident Capital Fund Vi LpMajor ShareholderSell250,000$15.79$3,947,500.00View SEC Filing  
1/19/2017Michael H KingInsiderSell5,000$19.00$95,000.00View SEC Filing  
1/17/2017Mark HirschhornVPSell10,000$17.84$178,400.00View SEC Filing  
1/9/2017Mark HirschhornVPSell5,000$17.50$87,500.00View SEC Filing  
12/15/2016Mark HirschhornVPSell5,000$16.60$83,000.00View SEC Filing  
12/14/2016Lp Chp IIIMajor ShareholderSell500,000$16.36$8,180,000.00View SEC Filing  
11/16/2016Mark HirschhornVPSell10,000$17.19$171,900.00View SEC Filing  
11/10/2016Mark HirschhornVPSell5,000$17.50$87,500.00View SEC Filing  
10/17/2016Mark HirschhornVPSell5,000$15.52$77,600.00View SEC Filing  
8/16/2016Jason N GorevicCEOSell40,000$17.92$716,800.00View SEC Filing  
8/11/2016Michael H KingInsiderSell25,000$17.20$430,000.00View SEC Filing  
8/8/2016Adam C VandervoortInsiderSell52,865$16.64$879,673.60View SEC Filing  
8/2/2016James K OutlandDirectorSell10,000$18.00$180,000.00View SEC Filing  
7/15/2016Jason N GorevicCEOSell5,000$15.45$77,250.00View SEC Filing  
6/29/2016James K OutlandDirectorSell10,000$15.00$150,000.00View SEC Filing  
6/29/2016Jason N GorevicCEOSell5,000$15.01$75,050.00View SEC Filing  
3/17/2016Dana G Jr. MeadDirectorBuy10,000$10.65$106,500.00View SEC Filing  
9/10/2015William H FristDirectorBuy4,500$22.54$101,430.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Teladoc (NYSE:TDOC)
Latest Headlines for Teladoc (NYSE:TDOC)
DateHeadline logoTeladoc Inc (TDOC) Rating Reiterated by Canaccord Genuity - May 24 at 9:34 PM logoTeladoc Inc (TDOC) CEO Sells $425,808.00 in Stock - May 24 at 7:40 PM logoBlog Coverage: Teladoc Expands Virtual Care Capabilities in Texas; Provides TMB Legal Suit Update - May 23 at 8:57 AM logoETFs with exposure to Teladoc, Inc. : May 22, 2017 - May 22 at 7:08 PM logoInsider Selling: Teladoc Inc (TDOC) VP Sells 100,000 Shares of Stock - May 19 at 7:40 PM logoTeladoc Expands Virtual Care Capabilities in Texas - May 19 at 6:03 PM logoKeyCorp Initiates Coverage on Teladoc Inc (TDOC) - May 17 at 5:16 PM logoTeladoc Inc (TDOC) Rating Lowered to Hold at Craig Hallum - May 13 at 12:32 AM logoETFs with exposure to Teladoc, Inc. : May 11, 2017 - May 12 at 2:12 AM logoZacks Investment Research Upgrades Teladoc Inc (TDOC) to "Hold" - May 11 at 1:06 PM logoTeladoc, Inc. :TDOC-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 - May 11 at 2:00 AM logoJason N. Gorevic Sells 15,000 Shares of Teladoc Inc (TDOC) Stock - May 10 at 11:22 PM logoTeladoc (TDOC) Q1 Loss Lower Than Expected, '17 View Intact - Nasdaq - May 10 at 10:24 AM logoTeladoc Inc (TDOC) Given a $28.00 Price Target by Robert W. Baird Analysts - May 9 at 11:02 PM logoTeladoc (TDOC) Q1 Loss Lower Than Expected, '17 View Intact - May 9 at 7:40 PM logoTeladoc, Inc. – Value Analysis (NYSE:TDOC) : May 9, 2017 - May 9 at 7:40 PM logoTeladoc Inc (TDOC) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS - May 9 at 11:24 AM logoTeladoc (TDOC) Q1 Loss Lower Than Expected, '17 View Intact - May 9 at 10:10 AM logoTeladoc Announces First Quarter 2017 Results - May 8 at 7:38 PM logoTeladoc Inc (TDOC) Releases FY17 Earnings Guidance - May 8 at 6:34 PM logoTeladoc Inc (TDOC) Releases Q2 Earnings Guidance - May 8 at 6:34 PM logoTeladoc reports 1Q loss - May 8 at 4:53 PM logoTeladoc, Inc. breached its 50 day moving average in a Bearish Manner : TDOC-US : May 8, 2017 - May 8 at 10:20 AM logoWhat's in Store for Teladoc (TDOC) this Earnings Season? - May 6 at 9:20 AM logoTeladoc Inc (TDOC) Set to Announce Quarterly Earnings on Monday - May 6 at 7:14 AM logoWhat's in Store for Teladoc (TDOC) this Earnings Season? - May 5 at 11:29 PM logoTeladoc (TDOC) Given Daily News Impact Rating of 0.57 - May 4 at 7:30 AM logo$42.13 Million in Sales Expected for Teladoc Inc (TDOC) This Quarter - May 4 at 1:37 AM logoTeladoc Inc (TDOC) Expected to Announce Earnings of -$0.33 Per Share - May 4 at 1:36 AM logoTeladoc Inc (TDOC) Receives Average Recommendation of "Buy" from Analysts - May 2 at 8:28 AM logoTeladoc (TDOC) Earning Somewhat Critical Media Coverage, Study Finds - May 1 at 3:48 PM logoTeladoc Inc (TDOC) Expected to Post Quarterly Sales of $42.13 Million - April 30 at 10:14 AM logoZacks: Brokerages Anticipate Teladoc Inc (TDOC) Will Announce Earnings of -$0.33 Per Share - April 28 at 8:56 AM logoTeladoc (TDOC) Given Daily News Impact Score of 0.29 - April 27 at 7:50 PM logoTeladoc (TDOC) Given Media Sentiment Rating of 0.31 - April 24 at 5:30 PM logoMichael H. King Sells 5,000 Shares of Teladoc Inc (TDOC) Stock - April 21 at 11:05 PM logoTeladoc Inc (TDOC) VP Sells $1,504,686.00 in Stock - April 21 at 11:02 PM logoCommit To Buy Teladoc At $22.50, Earn 13.7% Annualized Using Options - Nasdaq - April 20 at 9:03 PM logoTeladoc Inc (TDOC) Upgraded at TheStreet - April 19 at 8:11 PM logoTeladoc (TDOC) Receiving Favorable News Coverage, Study Finds - April 17 at 4:39 PM logoTeladoc (TDOC) Given Media Impact Score of 0.31 - April 13 at 4:41 PM logoTeladoc Inc (TDOC) Stock Rating Reaffirmed by Piper Jaffray Companies - April 11 at 6:29 PM logoTeladoc to Announce First Quarter 2017 Financial Results - April 11 at 9:18 AM logoPeregrine Capital Management Llc Buys Performance Food Group Co, REV Group, athenahealth, Sells ... - April 8 at 8:33 AM logo3 Stocks on the Motley Fool Money Radar This Week - April 7 at 12:58 PM logo-$0.33 EPS Expected for Teladoc Inc (TDOC) This Quarter - April 6 at 10:13 PM logoTeladoc Inc (TDOC) Cut to Neutral at Cantor Fitzgerald - April 6 at 7:39 PM logoTeladoc Inc (TDOC) Given Average Rating of "Buy" by Brokerages - April 5 at 10:04 AM logoTeladoc (TDOC) Up 7% Since Earnings Report: Can It Continue? - April 3 at 7:58 PM logoTeladoc Telehealth System Now Live at Jefferson Health - March 31 at 2:48 AM



Teladoc (TDOC) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by Staff